Brief Introduction: Spinal Muscular Atrophy is a neuromuscular illness that leads to advanced proximal muscle weakening and paralysis. It is...
Home
Kite Pharma received FDA approval for brexucabtagene autoleuceladult to treat patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia...
Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
Several indications and molecules were approved in July by FDA including the following: Asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component...
The Food and Drug Administration(FDA) approved avapritinib for adult patients with advanced systemic mastocytosis, including patients with aggressive systemic mastocytosis...
Novavax a Biotech firm claimed that its Covid-19 vaccine was shown to be safe and 90.4% effective overall in phase three...
The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
U.S. Food and Drug Administration (FDA) approved expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis...
According to the leading business data platform, Statista, it was found that a significant percentage of people in the UK...
The Food and Drug Administration (FDA) approved Biogen Inc's aducanumab drug using its Accelerated Approval pathway. Aducanumab targets amyloid plaque that...
